טוען...
Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo
Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties that is currently being examined in clinical trials to prevent and treat various diseases, including atherosclerosis, stroke, and cancer. However, no reports are available for verifying the pharmacological e...
שמור ב:
הוצא לאור ב: | Int J Biol Sci |
---|---|
Main Authors: | , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Ivyspring International Publisher
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807414/ https://ncbi.nlm.nih.gov/pubmed/27019631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.13815 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|